share

4-(4-Bromo-2-Fluoroanilino)-7-Hydroxy-6-Methoxyquinazoline CAS NO 196603-96-0


Unit Price:

CAS No.:196603-96-0

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

4-(4-Bromo-2-Fluoroanilino)-7-Hydroxy-6-Methoxyquinazoline is a high-purity, advanced pharmaceutical intermediate of significant importance in modern drug discovery and development. This compound serves as a critical building block in the synthesis of targeted kinase inhibitors, offering researchers a reliable and well-characterized starting material. It is primarily needed by pharmaceutical R&D laboratories, biotechnology companies, and fine chemical manufacturers engaged in the development of novel anticancer and therapeutic agents.

Application

  • Pharmaceutical Intermediate: A key precursor in the synthesis of novel tyrosine kinase inhibitor (TKI) candidates for oncology research.
  • Anticancer Drug Development: Used in the research and development of targeted therapies that interfere with specific signaling pathways in cancer cells.
  • Biochemical Research: Serves as a reference standard and a tool compound for studying enzyme inhibition and structure-activity relationships (SAR).
  • API Synthesis: Employed in the multi-step synthesis of Active Pharmaceutical Ingredients (APIs) for preclinical and clinical studies.
  • Fine Chemical Manufacturing: Utilized in the production of complex, high-value specialty chemicals for the life sciences sector.

Basic Information

Product Name 4-(4-Bromo-2-Fluoroanilino)-7-Hydroxy-6-Methoxyquinazoline
CAS No. 196603-96-0
Molecular Formula C₁₅H₁₁BrFN₃O₂
Molecular Weight 364.17 g/mol
Synonyms 4-[(4-Bromo-2-fluorophenyl)amino]-7-hydroxy-6-methoxyquinazoline; 7-Hydroxy-6-methoxy-4-[(4-bromo-2-fluorophenyl)amino]quinazoline; BIBF 1120 Intermediate; Nintedanib Impurity; Nintedanib Related Compound; Vargatef Intermediate; 4-(4-Bromo-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline; 196603-96-0
EINECS Contact for details

Quality Control

Our 4-(4-Bromo-2-Fluoroanilino)-7-Hydroxy-6-Methoxyquinazoline is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity suitable for research and development applications. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to cGMP guidelines where applicable to support our clients' regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep the container tightly sealed in a dry environment to protect the integrity of the material.

Specification

Item Specification
Appearance Off-white to light yellow powder
Identification (IR) Conforms to structure
Identification (HPLC) Conforms to reference
Assay (HPLC) ≥98.0%
Related Substances (HPLC) Total impurities ≤2.0%
Single Unknown Impurity ≤0.5%
Loss on Drying ≤0.5%
Residue on Ignition ≤0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.